Chinese Cloning Firm Pumps $15 Million into California Stem Cell Business
A Chinese firm that says it has the technology to clone human beings has invested $15 million in a stem cell company in Northern California.
The American firm is Cesca Therapeutics of Rancho Cordova, a suburb of Sacramento. The Chinese enterprise is BoyaLife Group, which has plans to clone one million cattle a year by 2020. In December, Rebecca Davis of …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.